HAL (N=68%)a LAP (N=35%)a LESS (N=12%)a p
Age (years) 46±13.7 47±15.5 49±15.1 0.64
Related:Unrelated Donor 41:27 28:7 6:6 0.07
Thymoglobulin Induction, n (%) 46 (68%) 23 (66%) 9 (75%) 0.84
Delayed Graft Function, n (%) 2 (3%) 2 (6%) 0 (0%) 0.60
Post-op Vascular Thrombosis, n (%) 5 (7%) 0 (0%) 0 (0%) 0.16
Graft Loss in 1st week, n (%) 4 (6%) 0 (0%) 0 (0%) 0.24
Mean Follow-up Time (days) 1952 845 226 <0.0001
One Year Acute Rejection Rate 3% 8% 0% 0.31
Overall Acute Rejection Rate 12% 14% 0% 0.40
Serum creatinine at 1 week (mg/dl) 1.89±1.19 1.56±0.96 1.71±0.76 0.26
Serum creatinine at 1 month (mg/dl) 1.66±0.85 1.45±0.61 1.88±1.03 0.25
Serum creatinine at 3 months (mg/dl) 1.51±0.53 1.43±0.56 1.48±0.39 0.81
Serum creatinine at 6 months (mg/dl) 1.50±0.51 1.41±0.48 1.42±0.29 0.77
Serum creatinine at 1 year (mg/dl) 1.48±0.52 1.35±0.58 --- 0.27
Serum creatinine at 2 years (mg/dl) 1.67±1.26 1.39±0.71 --- 0.40

HAL: hand-assisted laparoscopy, LAP: standard laparsopcy, LESS: laparoendoscopic single site surgery
aData is unavailable on 5 recipients in the HAL, 1 recipient in the LAP group, and 1 recipient in the LESS group
Table 5: Recipient Characteristics & Outcomes of Right Donors.